| |
| |
|
| Insider
Information: |
Arbuckle Stuart A |
| Relationship: |
Director |
| City: |
Cambridge, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,795 |
|
|
Indirect Shares
|
140 |
|
|
| Direct
Value |
$22,712,016 |
|
|
|
Indirect Value
|
$63,973 |
|
|
| Total
Shares |
62,935 |
|
|
| Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2021-02-17 |
4 |
D |
$211.75 |
$1,321,320 |
D/D |
(6,240) |
55,460 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2018-02-12 |
4 |
AS |
$150.78 |
$1,042,833 |
D/D |
(6,824) |
55,701 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-27 |
4 |
AS |
$287.16 |
$1,447,143 |
D/D |
(5,034) |
56,556 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-05-30 |
4 |
AS |
$329.82 |
$27,045 |
D/D |
(82) |
56,556 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-12-13 |
4 |
AS |
$399.00 |
$3,432,597 |
D/D |
(8,603) |
56,556 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-02-05 |
4 |
A |
$0.01 |
$207 |
D/D |
20,700 |
57,418 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,753 |
58,031 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-02-10 |
4 |
D |
$240.95 |
$2,154,575 |
D/D |
(8,942) |
58,621 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-21 |
4 |
AS |
$421.77 |
$1,519,637 |
D/D |
(3,603) |
59,439 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-10 |
4 |
AS |
$300.32 |
$54,073 |
D/D |
(180) |
60,880 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-09 |
4 |
AS |
$300.53 |
$1,710,817 |
D/D |
(5,690) |
60,996 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-10 |
4 |
OE |
$155.57 |
$9,956 |
D/D |
64 |
61,060 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-24 |
4 |
D |
$289.12 |
$1,362,912 |
D/D |
(4,714) |
61,590 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2021-02-11 |
4 |
AS |
$210.39 |
$1,085,593 |
D/D |
(5,156) |
61,700 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,573 |
62,525 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-20 |
4 |
AS |
$420.79 |
$2,021,475 |
D/D |
(4,804) |
63,042 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-05-02 |
4 |
AS |
$263.98 |
$80,778 |
D/D |
(306) |
64,760 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-05-16 |
4 |
AS |
$246.21 |
$33,408 |
D/D |
(133) |
64,760 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-02-24 |
4 |
D |
$227.86 |
$1,651,074 |
D/D |
(7,246) |
65,066 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-12-13 |
4 |
OE |
$187.53 |
$1,613,321 |
D/D |
8,603 |
65,159 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-22 |
4 |
AS |
$291.84 |
$706,679 |
D/D |
(2,401) |
66,304 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-09 |
4 |
OE |
$155.57 |
$299,628 |
D/D |
1,926 |
66,686 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2021-02-10 |
4 |
D |
$214.16 |
$664,110 |
D/D |
(3,101) |
66,856 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-15 |
4 |
OE |
$155.57 |
$1,022,250 |
D/D |
6,571 |
67,451 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
34,323 |
67,563 |
0 |
- |
|
192 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
